In a recent study, a Syk inhibitor fostamatinib attenuated NETs in neutrophils and reduced lupus characteristics (serum creatinine, proteinuria, and anti-dsDNA) in Fcgr2b-/- lupus mice (25). The gene discussed is SYK; the disease is systemic lupus erythematosus.